QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2018    专题：西安交通大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Efficacy and safety of a second-generation biodegradable polymer sirolimus-eluting stent: One-year results of the CREDIT 2 trial 期刊论文 CARDIOVASCULAR THERAPEUTICS, 2018, 卷号: 36 作者:  Xu, Kai;  Han, Yaling;  Xu, Bo;  Yang, Yuejin;  Wang, Geng 收藏  |  浏览/下载：8/0  |  提交时间：2019/11/19 interventional cardiology  randomized trial  biodegradable-polymer  drug-eluting stent   Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent (R) System) compared to TIVOLI in the Treatment of Patients with Coronary Heart Disease 会议论文 作者:  Han, Yaling;  Wang, Zhiyong;  Pei, Hanjun;  Zhang, Li;  Yang, Yuejin 收藏  |  浏览/下载：9/0  |  提交时间：2019/11/19 Differences in two-year outcomes for patients with non-ST-segment elevation myocardial infarction or unstable angina treated with medication only - findings from the EPICOR Asia study 会议论文 作者:  Zhou, Juan;  Huang, Xin;  Guo, Ning;  Wu, Yue;  Yu, Bo 收藏  |  浏览/下载：9/0  |  提交时间：2019/11/19 A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents 期刊论文 JACC: Cardiovascular Interventions, 2018, 卷号: 11, 页码: 287-297 作者:  Han, Yaling;  Xu, Bo;  Fu, Guosheng;  Wang, Xiaozeng;  Xu, Kai 收藏  |  浏览/下载：15/0  |  提交时间：2019/11/26 bioresorbable scaffolds  drug-eluting stent(s)  randomized controlled trial   In-hospital outcomes of dual loading antiplatelet therapy in patients 75 years and older with acute coronary syndrome undergoing percutaneous coronary intervention: Findings from the CCC-ACS (Improving Care for Cardiovascular Disease in China-acute coronary syndrome) project 期刊论文 Journal of the American Heart Association, 2018, 卷号: 7 作者:  Zhao, Guanqi;  Zhou, Mengge;  Ma, Changsheng;  Huo, Yong;  Smith, Sidney C. 收藏  |  浏览/下载：61/0  |  提交时间：2019/11/26 Acute coronary syndrome  Antiplatelet therapy  Elderly  Loading dose  Percutaneous coronary intervention   Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study 期刊论文 CARDIOVASCULAR DRUGS AND THERAPY, 2018, 卷号: 32, 页码: 47-56 作者:  Gao, Runlin;  Wu, Yongjian;  Liu, Hengliang;  Su, Guohai;  Yuan, Zuyi 收藏  |  浏览/下载：11/0  |  提交时间：2019/11/26 Ticagrelor  Chinese patients  Safety  Acute coronary syndrome   Prognostic value of the age, creatinine, and ejection fraction score for non-infarct-related chronic total occlusion revascularization after primary percutaneous intervention in acute ST-elevation myocardial infarction patients: A retrospective study 期刊论文 JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2018, 卷号: 31, 页码: 33-40 作者:  Deng, Jie;  Wang, Xiaozeng;  Shi, Yana;  Zhao, Xin;  Han, Yaling 收藏  |  浏览/下载：13/0  |  提交时间：2019/11/26 chronic total occlusions (CTO)  age  ST-segment elevation myocardial infarction (STEMI)  percutaneous coronary intervention (PCI)  creatinine  and ejection fraction (ACEF) score